Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$15.35 - $18.82 $2,977 - $3,651
194 Added 1.02%
19,125 $354,000
Q4 2023

Feb 13, 2024

SELL
$8.99 - $16.86 $1,240 - $2,326
-138 Reduced 0.72%
18,931 $307,000
Q3 2023

Nov 13, 2023

BUY
$10.81 - $22.96 $4,183 - $8,885
387 Added 2.07%
19,069 $263,000
Q2 2023

Aug 04, 2023

BUY
$17.19 - $24.34 $4,280 - $6,060
249 Added 1.35%
18,682 $412,000
Q1 2023

May 12, 2023

BUY
$17.67 - $26.07 $1,378 - $2,033
78 Added 0.42%
18,433 $400,000
Q4 2022

Feb 10, 2023

SELL
$16.95 - $25.07 $2,288 - $3,384
-135 Reduced 0.73%
18,355 $334,000
Q3 2022

Nov 14, 2022

BUY
$14.64 - $26.7 $6,763 - $12,335
462 Added 2.56%
18,490 $421,000
Q2 2022

Aug 12, 2022

BUY
$10.54 - $24.2 $110,901 - $254,632
10,522 Added 140.18%
18,028 $249,000
Q1 2022

May 13, 2022

SELL
$20.81 - $37.29 $5,389 - $9,658
-259 Reduced 3.34%
7,506 $171,000
Q4 2021

Feb 11, 2022

SELL
$32.99 - $58.55 $261,577 - $464,242
-7,929 Reduced 50.52%
7,765 $289,000
Q3 2021

Nov 12, 2021

BUY
$42.03 - $60.5 $84,732 - $121,968
2,016 Added 14.74%
15,694 $664,000
Q2 2021

Aug 13, 2021

BUY
$29.51 - $44.62 $161,773 - $244,606
5,482 Added 66.89%
13,678 $609,000
Q1 2021

May 07, 2021

BUY
$32.95 - $44.24 $691 - $929
21 Added 0.26%
8,196 $295,000
Q4 2020

Feb 12, 2021

SELL
$27.5 - $45.75 $1,237 - $2,058
-45 Reduced 0.55%
8,175 $326,000
Q3 2020

Nov 04, 2020

BUY
$16.04 - $28.94 $60,567 - $109,277
3,776 Added 84.97%
8,220 $238,000
Q2 2020

Aug 12, 2020

BUY
$9.2 - $17.06 $1,343 - $2,490
146 Added 3.4%
4,444 $73,000
Q1 2020

May 04, 2020

SELL
$8.36 - $17.03 $2,073 - $4,223
-248 Reduced 5.46%
4,298 $41,000
Q4 2019

Feb 05, 2020

BUY
$14.59 - $18.9 $4,187 - $5,424
287 Added 6.74%
4,546 $74,000
Q3 2019

Nov 08, 2019

BUY
$15.7 - $20.98 $235 - $314
15 Added 0.35%
4,259 $71,000
Q2 2019

Aug 13, 2019

BUY
$15.2 - $19.42 $64,508 - $82,418
4,244 New
4,244 $72,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.11B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.